VOYA Investment Management
DNA icon

VOYA Investment Management’s Ginkgo Bioworks DNA Stock Holding History

VOYA Investment Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,783
Closed -$121K – 2500
2025
Q2 		$121K Buy
+10,783
New +$83.5K ﹤0.01% 2448
2024
Q2 		– Sell
-6,073
Closed -$281K – 2846
2024
Q1 		$281K Buy
6,073
+97
+2% +$5.02K ﹤0.01% 2282
2023
Q4 		$404K Sell
5,976
-86
-1% -$5.27K ﹤0.01% 2187
2023
Q3 		$439K Sell
6,062
-112
-2% -$8.95K ﹤0.01% 2108
2023
Q2 		$459K Buy
6,174
+2,256
+58% +$134K ﹤0.01% 2131
2023
Q1 		$208K Sell
3,918
-82
-2% -$5.2K ﹤0.01% 2512
2022
Q4 		$270K Buy
4,000
+174
+5% +$16K ﹤0.01% 2402
2022
Q3 		$477K Sell
3,826
-91
-2% -$10.8K ﹤0.01% 2052
2022
Q2 		$373K Buy
+3,917
New +$478K ﹤0.01% 2020

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management's DNA Position: Q3 2025 in Review

VOYA Investment Management sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 10,783 shares — an estimated $121K sold.

VOYA Investment Management first reported a position in DNA in Q2 2022 and held it in 9 quarters. The position peaked at $477K in Q3 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • VOYA Investment Management reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 10,783 Ginkgo Bioworks shares in Q3 2025, an estimated $121K.
  • VOYA Investment Management first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 9 quarters.
  • VOYA Investment Management's Ginkgo Bioworks position peaked at $477K in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.